Study compares the incidence rates of pediatric T1D and 2D during and before SARS-CoV-2.
First Drug Approved for Niemann-Pick Disease Type C
The FDA on Friday approved arimoclomol (Miplyffa) as the first treatment specifically for the genetic disorder Niemann-Pick disease type C (NPC), an ultra-rare and progressive